Intra-Cellular Therapies, Inc.
2019 Q4 - 2025 Q1 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q1 | 5/15/2025 | 935 | 0.0% | 7,085 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,811 | 0.0% | 21,689 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,614 | 0.0% | 22,057 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,491 | 0.0% | 21,774 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 3,670 | 0.0% | 53,041 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 5,711 | 0.0% | 79,742 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 2,794 | 0.0% | 53,634 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 2,399 | 0.0% | 37,881 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,000 | 0.0% | 36,929 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 1,947 | 0.0% | 36,796 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 1,677 | 0.0% | 36,043 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 2,092 | 0.0% | 36,654 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 1,999 | 0.0% | 32,670 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 1,801 | 0.0% | 34,419 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,299 | 0.0% | 34,840 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 1,564 | 0.0% | 38,312 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 1,221 | 0.0% | 35,990 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 1,222 | 0.0% | 38,432 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 927 | 0.0% | 36,118 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 797 | 0.0% | 31,643 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 482 | 0.0% | 31,357 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 897 | 0.0% | 26,148 | 12/31/2019 |